✨ Your Portfolio is fetched and updated from zerodha.
Nano Hospitals

Vaidya Sane Ayurved Laboratories Ltd.

MADHAVBAUG

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹302 Cr.
P/E
42.29

Vaidya Sane Ayurved Laboratories Ltd.

  • Vaidya Sane Ayur Lab
  • Gennex Lab
  • Trident Lifeline
FAQs on Vaidya Sane Ayurved Laboratories Ltd. Shareprice

Vaidya Sane Ayur Lab has given better returns compared to its competitors.
Vaidya Sane Ayur Lab has grown at ~-4.4% over the last 2yrs while peers have grown at a median rate of -9.28%

Vaidya Sane Ayur Lab is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Vaidya Sane Ayur Lab is 42.29, while 3 year average PE is 59.24.
Also latest EV/EBITDA of Vaidya Sane Ayur Lab is 19.65 while 3yr average is 13.27.

View FAQ's On Business
Growth Table
  • Vaidya Sane Ayurved Laboratories Ltd.
  • Gennex Lab
  • Trident Lifeline
Balance Sheet
  • Vaidya Sane Ayurved Laboratories Ltd.
  • Gennex Lab
  • Trident Lifeline
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Vaidya Sane Ayurved Laboratories Ltd.
  • Gennex Lab
  • Trident Lifeline
Cash Flow
  • Vaidya Sane Ayurved Laboratories Ltd.
  • Gennex Lab
  • Trident Lifeline
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Vaidya Sane Ayurved Laboratories Ltd.
  • Gennex Lab
  • Trident Lifeline
Quarterly Results
  • Vaidya Sane Ayurved Laboratories Ltd.
  • Gennex Lab
  • Trident Lifeline
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Vaidya Sane Ayurved Laboratories Ltd. Financials

Balance sheet of Vaidya Sane Ayur Lab is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Vaidya Sane Ayur Lab is increasing.
Latest net debt of Vaidya Sane Ayur Lab is -₹0.9 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹32.47 Crs.

The profit is oscillating.
The profit of Vaidya Sane Ayur Lab is ₹6.67 Crs for TTM, ₹1.98 Crs for Mar 2024 and ₹4.83 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vaidya Sane Ayur Lab latest dividend payout ratio is 5.44% and 3yr average dividend payout ratio is 5.44%

Companies resources are allocated to majorly productive assets like Plant & Machinery

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech